Pharmafile Logo

symptoms

- PMLiVE

FDA ‘names and shames’ generic-blocking pharma companies

Celgene and Actelion top the list of offenders

- PMLiVE

Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more

A rapid round up of pharma, biotech and healthcare news

Empowered patients improve outcomes

This white paper co-authored by our own Caroline Benson and Guy Yeoman, MediPaCe, discusses why non-adherence is occurring, how patients’ can be better engaged with their conditions and treatments and...

Cuttsy + Cuttsy

- PMLiVE

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

A rapid round up of pharma, biotech and healthcare news

It’s nice, but it’s not an infographic

If you want to know if you’ve created an infographic, you can have a go with our flow diagram

Cuttsy + Cuttsy

Celgene building

Celgene boosts CAR-T stake again with Bluebird Bio deal

The US biotech could receive $70m in development milestones for the candidate

- PMLiVE

Six degrees of participation

Exploring the ongoing journey to patient empowerment and examining how pharma can play a part in more participatory models of care

- PMLiVE

Sun Pharma passes milestone with novel psoriasis drug approval

Ilumya will treat adults with a moderate-to-severe form of the skin condition

Celgene building

Celgene bulks up pipeline again with $2.1bn Prothena deal

Acquires candidates with potential in Alzheimer’s, ALS and dementia

Celgene building

FDA turns down Celgene’s filing for multiple sclerosis drug

The application needs additional pharmacology information according to the US agency

Bridging pharma’s digital gap

Although still playing catch-up, the industry is being transformed by technology

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links